Skip to main content
Equibles

XTX Topco Ltd

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1828301 LONDON, X0
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$901,418
+$857,465 QoQ
Shares Held
245,618
+1615.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#77
of 344 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. RXRX ranks #127 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 30,522 $19,031,687
2 ASND
Ascendis Pharma A/S
 43,289 $11,546,042
3 BBIO
BridgeBio Pharma, Inc.
 116,611 $8,685,187
4 MRNA
Moderna, Inc.
 123,281 $8,633,368
5 JAZZ
Jazz Pharmaceuticals plc
 30,496 $7,348,621
6 KYMR
Kymera Therapeutics, Inc.
 61,501 $7,052,319
7 CYTK
Cytokinetics Inc
 80,743 $6,878,496
8 PTCT
Ptc Therapeutics, Inc.
 81,923 $6,682,459

All Filings in RXRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $901,418 245,618
2026-03-31 $43,953 14,317
2025-12-31 $195,943 47,908
2025-09-30 $114,616 23,487
2025-06-30 $3,193,902 631,206
2024-12-31 $564,777 83,547
2023-12-31 $151,341 15,349
2023-03-31 $321,080 48,138
2022-12-31 $138,887 18,014
2022-09-30 $109,592 10,300